author-photo

Agustina Salem

National Scientific and Technical Research Council

2

Papers

6

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (6)
Benefits of metronomic therapy targeting muscarinic receptors in breast cancer as a sensitizer of cells to classic chemotherapy with paclitaxel

2018
Show All
- Source
- Cite
- Save
Citations (0)